Xencor, Inc.
Modulation of T cells with bispecific antibodies and Fc fusions

Last updated:

Abstract:

The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.

Status:
Grant
Type:

Utility

Filling date:

8 Mar 2019

Issue date:

17 Aug 2021